IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
IQVIA Complete Consent
IQVIA is the only eConsent provider that can support all trial types and business models, from decentralized to traditional, from full-service to SaaS and every combination in between. Read more about the consent solution that patients and sites are eager to use.
Five Easy Investigator Payment Fixes to Improve Site Relations
Authors review five common issues that delay site payments and offer recommendations to resolve these issues and improve efficiency and satisfaction. Read more.
Alnylam Puts Sites and Patients First with IQVIA Technologies Investigator Site Portal
Read how the IQVIA Investigator Site Portal enables Alnylam's patient-centered and site-first approach.
IQVIA eTMF Fact Sheet
Lighten your operational burdent by leveraging our experts to manage and monitor your eTMF. Read more.
Clinical Trial Payments Fact Sheet
IQVIA is the # 1 payments provider in the world with over 12 years experience and offers technology enabled payment services supported by experts all over the globe. Read more.
How to Boost Support to Sites with Digital Clinical Technologies During the COVID-19 Crisis and Beyond
This article discusses how digital clinical technologies haved gon from “nice-to-have” to mission-critical during COVID-19. The author dicusses five areas where technologies can boost support to sites and enable innovative drug development to continue.
Digital Site Suite Fact Sheet
This digital site suite empowers clinical trial teams with SaaS and services that reduce site administrative burden and help studies run more smoothly and rapidly